Efficiency of Continuous Glucose Monitoring in Critically Ill Patients

• Status: Completed
• Trial end date: 2008-08-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine whether, real-time continuous glucose monitoring in critically ill patients with intensive insulin therapy would increase the percentage of time of normoglycemia, defined as glucose levels below 110 mg/dl.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Medical University of Vienna
• Treatments: Insulin; Insulin Aspart; Insulin degludec, insulin aspart drug combination; Insulin, Globin Zinc; Insulin, Long-Acting

Criteria

Inclusion Criteria:

• Admitted critically ill patients expected to stay >48h on the ICU after initiation of intensive insulin therapy.

• Age > 18 years.

Exclusion Criteria:

• Admitted patients expected to stay <48h

• Age ≤ 18 years